PRKN and metabolic dysfunction-associated steatotic liver disease: Moreover, palmitate-impaired mitophagy is also restored by puerarin via increasing PINK1/Parkin expression (Chen et al., 2018) Thus, these results indicate that puerarin could be a potential therapeutic agent for the treatment of NAFLD.